Subpopulations in aMPV vaccines are unlikely to be the only cause of reversion to virulence

Highlights • Development of different NGS protocols for aMPV full genome sequencing. • First study investigating aMPV vaccine subpopulation using NGS. • Comparison of identified SNV with attenuation/reversion to virulence markers. • Evidence of the role of intra-vaccine variability in vaccine revers...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2015-05, Vol.33 (21), p.2438-2441
Hauptverfasser: Franzo, G, Naylor, C.J, Drigo, M, Croville, G, Ducatez, M.F, Catelli, E, Laconi, A, Cecchinato, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Development of different NGS protocols for aMPV full genome sequencing. • First study investigating aMPV vaccine subpopulation using NGS. • Comparison of identified SNV with attenuation/reversion to virulence markers. • Evidence of the role of intra-vaccine variability in vaccine reversion to virulence.
ISSN:0264-410X
1873-2518
0264-410X
DOI:10.1016/j.vaccine.2015.03.092